According to VBI Vaccines
's latest financial reports the company has $7.52 M in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-12-31 | $64.16 M | -55.41% |
2021-12-31 | $0.14 B | -16.2% |
2020-12-31 | $0.17 B | 94.56% |
2019-12-31 | $88.25 M | -10.07% |
2018-12-31 | $98.13 M | -18.08% |
2017-12-31 | $0.11 B | 43.06% |
2016-12-31 | $83.73 M | 586.66% |
2015-12-31 | $12.19 M | |
2015-03-31 | $80.94 M | -48.42% |
2014-03-31 | $0.15 B | -10.52% |
2013-03-31 | $0.17 B | -4.98% |
2012-03-31 | $0.18 B | 16.69% |
2011-03-31 | $0.15 B | 3118.65% |
2010-03-31 | $4.91 M | 293.5% |
2009-03-31 | $1.24 M | -14.46% |
2008-03-31 | $1.46 M | 6.32% |
2007-03-31 | $1.37 M | 29.09% |
2006-03-31 | $1.06 M | 161.9% |
2005-03-31 | $0.4 M | 232.63% |
2004-03-31 | $0.12 M | -276.15% |
2003-03-31 | $-0.07 M | -13.14% |
2002-03-31 | $-0.08 M | -116.31% |
2001-03-31 | $0.48 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Onconova Therapeutics ONTX | $10.67 M | 41.78% | ๐บ๐ธ USA |
Curis CRIS | $19.67 M | 161.33% | ๐บ๐ธ USA |
Myriad Genetics MYGN | $0.78 B | 10,305.21% | ๐บ๐ธ USA |